Article metrics
PDF
Other content recommended for you
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Better recognition for research participants: what society should learn from covid-19
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Ethics of research at the intersection of COVID-19 and black lives matter: a call to action
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- Payment of COVID-19 challenge trials: underpayment is a bigger worry than overpayment
- Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
- UK Research Ethics Committee’s review of the global first SARS-CoV-2 human infection challenge studies
- A framework for the promotion of ethical benefit sharing in health research